Nomad Power Solutions (NMAD) EV to CFO (2010 - 2025)
Nomad Power Solutions (NMAD) posted EV to CFO of 17.1 for Q4 2025, up 38.57% on a QoQ basis from 27.84 in Q3 2025, and down 190.33% year-over-year from 18.94 in Q4 2024.
Analysis
Nomad Power Solutions (NMAD) EV to CFO (2010 - 2025) Analysis & Trends
Nomad Power Solutions has reported EV to CFO for 16 years, with the latest figure at 17.1 in Q4 2025.
- On a quarterly basis, EV to CFO fell 190.33% year-over-year to 17.1 in Q4 2025; TTM through Dec 2025 was 6.06, a 443.71% decrease from a year earlier, with the FY2025 full-year figure at 1.64, down 46.98% from the prior year.
- EV to CFO was 17.1 for Q4 2025 at Nomad Power Solutions, up from 27.84 in the prior quarter.
- The five-year high for EV to CFO was 0.43 in Q3 2023, with the low at 426.44 in Q1 2021.
- Average EV to CFO over 5 years is 91.76, with a median of 22.47 recorded in 2025.
- The sharpest annual moves came in 2023 and 2025: EV to CFO surged 99.42% in 2023, then tumbled 938.06% in 2025.
- Over 5 years, EV to CFO stood at 138.43 in 2021, then jumped by 52.45% to 65.82 in 2022, then soared by 98.18% to 1.2 in 2023, then plunged by 391.05% to 5.89 in 2024, then sank by 190.33% to 17.1 in 2025.
- The last three EV to CFO figures came in at 17.1 (Q4 2025), 27.84 (Q3 2025), and 3.26 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Nomad Power Solutions | 49.59 Mn | 49.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -17.10 |
| Sep 30, 2025 | -27.84 |
| Jun 30, 2025 | -3.26 |
| Mar 31, 2025 | -3.28 |
| Dec 31, 2024 | -5.89 |
| Sep 30, 2024 | -2.68 |
| Jun 30, 2024 | -3.34 |
| Mar 31, 2024 | -5.31 |
| Dec 31, 2023 | -1.20 |
| Sep 30, 2023 | -0.43 |
| Jun 30, 2023 | -5.86 |
| Mar 31, 2023 | -105.54 |
| Dec 31, 2022 | -65.82 |
| Sep 30, 2022 | -73.82 |
| Jun 30, 2022 | -96.67 |
| Mar 31, 2022 | -159.70 |
| Dec 31, 2021 | -138.43 |
| Sep 30, 2021 | -301.73 |
| Jun 30, 2021 | -390.84 |
| Mar 31, 2021 | -426.44 |